VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+4.68%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$223M
AUM Growth
-$41.4M
(-16%)
Cap. Flow
-$33.4M
Cap. Flow
% of AUM
-14.95%
Top 10 Holdings %
Top 10 Hldgs %
11%
Holding
420
New
44
Increased
50
Reduced
231
Closed
47
Top Buys
| 1 |
The Mosaic Company
MOS
|
$2.75M |
| 2 |
STR
Sitio Royalties
STR
|
$2.32M |
| 3 |
Copel
ELP
|
$2.31M |
| 4 |
Vale
VALE
|
$2.26M |
| 5 |
Nutrien
NTR
|
$2.24M |
Top Sells
| 1 |
Boise Cascade
BCC
|
$2.62M |
| 2 |
Extra Space Storage
EXR
|
$2.49M |
| 3 |
Canadian Natural Resources
CNQ
|
$2.46M |
| 4 |
Imperial Oil
IMO
|
$2.45M |
| 5 |
Avient
AVNT
|
$2.42M |
Sector Composition
| 1 | Materials | 20.16% |
| 2 | Real Estate | 20.02% |
| 3 | Healthcare | 16.51% |
| 4 | Energy | 10.55% |
| 5 | Utilities | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Avidity Biosciences
RNA
$6.48B
| $116K | 0.05% |
6,286
-378
| -6% | -$6.98K |
|
|
CLVS
277
DELISTED
Clovis Oncology, Inc.
CLVS
| $116K | 0.05% |
57,437
-3,399
| -6% | -$6.87K |
|
278
AbCellera Biologics
ABCL
$1.26B
| $115K | 0.05% |
11,784
-698
| -6% | -$6.81K |
|
|
AUTL
279
Autolus Therapeutics
AUTL
$389M
| $115K | 0.05% |
27,536
-1,639
| -6% | -$6.85K |
|
|
GTHX
280
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $115K | 0.05% |
15,188
-900
| -6% | -$6.82K |
|
|
VBIV
281
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $115K | 0.05% |
2,307
-137
| -6% | -$6.83K |
|
282
Mersana Therapeutics
MRSN
$34M
| $113K | 0.05% |
1,132
-67
| -6% | -$6.69K |
|
283
Arbutus Biopharma
ABUS
$805M
| $112K | 0.05% |
37,448
-2,227
| -6% | -$6.66K |
|
284
RAPT Therapeutics
RAPT
$214M
| $112K | 0.05% |
635
-39
| -6% | -$6.88K |
|
285
Repare Therapeutics
RPTX
$72.6M
| $112K | 0.05% |
7,891
-464
| -6% | -$6.59K |
|
286
Akero Therapeutics
AKRO
$3.58B
| $111K | 0.05% |
7,802
-464
| -6% | -$6.6K |
|
287
Denali Therapeutics
DNLI
$2.26B
| $110K | 0.05% |
3,433
-200
| -6% | -$6.41K |
|
|
HGEN
288
DELISTED
HUMANIGEN, INC.
HGEN
| $110K | 0.05% |
36,572
-2,168
| -6% | -$6.52K |
|
289
ALX Oncology
ALXO
$65.3M
| $109K | 0.05% |
6,465
-379
| -6% | -$6.39K |
|
290
Rocket Pharmaceuticals
RCKT
$354M
| $108K | 0.05% |
6,792
-400
| -6% | -$6.36K |
|
291
Q32 Bio
QTTB
$20.4M
| $108K | 0.05% |
1,972
-116
| -6% | -$6.35K |
|
292
Alector
ALEC
$305M
| $105K | 0.05% |
7,356
-443
| -6% | -$6.32K |
|
293
MeiraGTx Holdings
MGTX
$619M
| $105K | 0.05% |
7,579
-453
| -6% | -$6.28K |
|
|
TPTX
294
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $105K | 0.05% |
3,893
-238
| -6% | -$6.42K |
|
295
Arrowhead Research
ARWR
$4.02B
| $104K | 0.05% |
2,258
-142
| -6% | -$6.54K |
|
296
Codexis
CDXS
$218M
| $104K | 0.05% |
5,023
-292
| -5% | -$6.05K |
|
297
Cullinan Oncology
CGEM
$413M
| $104K | 0.05% |
9,941
-595
| -6% | -$6.23K |
|
|
FMTX
298
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $104K | 0.05% |
11,234
-668
| -6% | -$6.18K |
|
299
Editas Medicine
EDIT
$248M
| $103K | 0.05% |
5,425
-315
| -5% | -$5.98K |
|
|
KNTE
300
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $103K | 0.05% |
9,184
-541
| -6% | -$6.07K |
|